Member Info for nlondon1234

Thanks regulator.

I was wondering if anyone knew if lateral flow tests have been rolled out in the usa by any company/state on a large scale so far?

Anyway it will be interesting to see where the company go either way.

Mike must be watching the board.Fess up!Which one of you?;

He puts it about on aim ole richard and hope he has the best intentions with c4xd.However all buying is good.I do remember when he trashed Jog's sp a couple of years back i believe.

I'll break the silence!:pFolk on ther alba board are referencing the mightlily high ilmenite price today.I hadn't checked lately.I'm nearly always early to the party.. just hoping i don't leave too soon!

After a few years out in the wild.. why it finally be c4xd's time to shine?

I heard that on the radio too.Odx rallied into the close today.

Thanks for the update.Not sure.Seems to be instils anyway.Huge amounts being traded.Who knows?Maybe they have already know something about something.Wouldn’t want to defame anyone but wouldn’t surprise me!

The buzz of a shorter winner is good but not if you then lose it in a usual aim dog as the odds are generally against the aim punter.Mabs have got more attention lately and been proven more so as efficient treatments due to covid and have great potential outside of Covid treatments too.Great time to be in tils as a lth.Time in tils has good odds of paying off!

I know at times.Gdr have gone up on an investors presentation which can’t reveal any price sensitive news as it would be obviously illegal.Wonder if it will sell off tomorrow or just carry on going up until the presentation.

That’s the problem with Microcap aim shared.Theyre too small for many funds to invest in, often sentiment led even with potentially great products and the odds are heavily stacked against the punter.For every ggp and eua success there are hundreds of unloved laggards not going anywhere.The irony here is there are aim shares with less revenue and higher Macaps and profitable shares with dividends at 40 mill Macap on aim that no punter is interested in.A company really needs to invest in the story and or to grab the punters attention usually.Twitter rumours and Twitter pundits with big followings are great too.

D’oh!For ‚one of his worst ever investments‘ read ‚trades‘ as selling a call is a trade obviously!

Ig merged with tastytrade.Tom the ceo and tastytrade have circa 10 percent of ig‘s equity now.Tom was all for not ceasing trading in GameStop even though the calls he shorted were at one point one of his worst ever investments.I doubt it is due to a counterparty risk now.More likely a change of direction and re deployment of investment capital amongst the group..Maybe it wasn’t that profitable overall.Tom wants to do a lot of new stuff as a constant innovator of products.That‘s why he merged.

I agree.Unless tils get on the fast track phase 1 trials government program (
i think somebody mentioned it a few weeks back), the covid "hype" phase (tlsa being confused with tesla or whatever) is probably over for now (who knows the eventual twists and turns with covid).

Thus, tils is a longer term play (although there could be a preclinical licencing option, but i don't think the bod and main shareholder would want that) and however good the potential it will take time to realise it as in normal times with pharma.I doubt there will be big partners until at least after a phase 1/2 trial at least as there are still too many unknowns.That's the big reward eventually with small caps if they work out and it takes a long time and patience often!

Did you contact tils pr with your question or the company directly?

for trial results..I've just got a feeling!Weird move down then straight up again this week.The overheated us markets must crash properly soon and C4xd must be a great place to be!

CEO is getting sbi involved with more than one big pilot trials so spreading risk.It is a volatile share due to sbi’s COVID business and the current backlog of regular business (should pick up this year).CEO is clearly competent as he got the COVID business off the ground through existing nhs contacts and successful work I’m assuming.Who knows exactly where COVID testing is going but trading is too tough for me to figure out without definite constant insider straight from the horses mouth government policy knowledge.So I’m personally sticking with the ceo as he has delivered so far, reading rnses and ignoring day to day so unless I want to buy more or sell it is irrelevant without material rnsable news.That’s just my personal philosophy though.

Wouldn’t base any personal ‘trading’ algorithm off this website’s algorithm for classifying ‘buys’ and ‘sells’.Buy better, accurate data if you want to attempt creating your own trading program based off buys and sells.Good luck!

A lot of big trades in C4xd.Didn’t shift the sp hugely in one or other direction as a ratio to current Macao.We’re deffo an institutionally driven share at the mo, which is fine by me (too much hour by hour drama in pi driven shares).

Good news and got my vaccination yesterday in Surrey and under 40.Really well organised down there with lots of fab volunteers (apparently alot of folk in the hospitality industries).Really inspiring!Plus Brentford didn’t lose against Sheffield Wednesday yesterday.Not a fan of regression!Hope all are happy and well.

We‘ve all had that feeling at times.That‘s one of the problems with looking at your shares and their sp often.Sometimes it‘s just better for your mental health and portfolio valuation if you don‘t as it‘s all too easy to concentrate on a few down days over months/year and want to sell.Probably why most investors outperform traders over time (unless you have an in with Renaissance tech).

If you believe in the company and their products, it’s worth just fort getting about sp unless you want to buy or sell.I check company rnses instead.